379 related articles for article (PubMed ID: 33474856)
1. Total IgE as a Marker for Chronic Spontaneous Urticaria.
Altrichter S; Fok JS; Jiao Q; Kolkhir P; Pyatilova P; Romero SM; Scheffel J; Siebenhaar F; Steinert C; Terhorst-Molawi D; Xiang YK; Church MK; Maurer M
Allergy Asthma Immunol Res; 2021 Mar; 13(2):206-218. PubMed ID: 33474856
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of Autoimmune Chronic Spontaneous Urticaria.
Larenas-Linnemann D
Curr Allergy Asthma Rep; 2023 Dec; 23(12):655-664. PubMed ID: 38064133
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune chronic spontaneous urticaria.
Kolkhir P; Muñoz M; Asero R; Ferrer M; Kocatürk E; Metz M; Xiang YK; Maurer M
J Allergy Clin Immunol; 2022 Jun; 149(6):1819-1831. PubMed ID: 35667749
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both.
Chen Y; Yu M; Huang X; Tu P; Shi P; Maurer M; Zhao Z
World Allergy Organ J; 2021 Jan; 14(1):100501. PubMed ID: 33510832
[TBL] [Abstract][Full Text] [Related]
5. Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU.
Sella JA; Ferriani MPL; Melo JML; Trevisan Neto O; Zanetti MET; Cordeiro DL; Lemos JE; Barros SA; Aragon DC; Arruda LK
J Allergy Clin Immunol Glob; 2023 Nov; 2(4):100159. PubMed ID: 37781653
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
Metz M; Staubach P; Bauer A; Brehler R; Gericke J; Kangas M; Ashton-Chess J; Jarvis P; Georgiou P; Canvin J; Hillenbrand R; Erpenbeck VJ; Maurer M
Theranostics; 2017; 7(5):1266-1276. PubMed ID: 28435464
[No Abstract] [Full Text] [Related]
7. Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU).
Jang JH; Yang EM; Lee Y; Ye YM; Moon J; Ryu MS; Park HS
World Allergy Organ J; 2022 Feb; 15(2):100629. PubMed ID: 35280503
[TBL] [Abstract][Full Text] [Related]
8. The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change.
Ertas R; Ozyurt K; Atasoy M; Hawro T; Maurer M
Allergy; 2018 Mar; 73(3):705-712. PubMed ID: 29083482
[TBL] [Abstract][Full Text] [Related]
9. Chronic spontaneous urticaria: new evidences on the role of autoimmunity.
Xiang YK; Guloglu S; Elieh-Ali-Komi D; Kocatürk E
Curr Opin Allergy Clin Immunol; 2023 Oct; 23(5):438-445. PubMed ID: 37459281
[TBL] [Abstract][Full Text] [Related]
10. In chronic spontaneous urticaria, IgE against staphylococcal enterotoxins is common and functional.
Altrichter S; Hawro T; Liedtke M; Holtappels G; Bachert C; Skov PS; Maurer M
Allergy; 2018 Jul; 73(7):1497-1504. PubMed ID: 29315616
[TBL] [Abstract][Full Text] [Related]
11. Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment.
Kolkhir P; Church MK; Altrichter S; Skov PS; Hawro T; Frischbutter S; Metz M; Maurer M
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):318-325.e5. PubMed ID: 31472293
[TBL] [Abstract][Full Text] [Related]
12. IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria.
Schmetzer O; Lakin E; Topal FA; Preusse P; Freier D; Church MK; Maurer M
J Allergy Clin Immunol; 2018 Sep; 142(3):876-882. PubMed ID: 29208545
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study.
Ghazanfar MN; Holm JG; Thomsen SF
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1761-1767. PubMed ID: 29729103
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune Diseases and Low Baseline IgE in Chronic Spontaneous Urticaria: A Clinical and Therapeutic Prospective Analysis in Real-Life Clinical Practice.
Pesqué D; March-Rodríguez Á; Curto-Barredo L; Soto D; Gimeno R; Pujol RM; Giménez-Arnau AM
J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3763-3771.e5. PubMed ID: 37716526
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers of chronic spontaneous urticaria and their clinical implications.
Asero R; Cugno M
Expert Rev Clin Immunol; 2021 Mar; 17(3):247-254. PubMed ID: 33496195
[No Abstract] [Full Text] [Related]
16. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
Kaplan AP; Giménez-Arnau AM; Saini SS
Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
[TBL] [Abstract][Full Text] [Related]
17. Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.
Marzano AV; Genovese G; Casazza G; Fierro MT; Dapavo P; Crimi N; Ferrucci S; Pepe P; Liberati S; Pigatto PD; Offidani A; Martina E; Girolomoni G; Rovaris M; Foti C; Stingeni L; Cristaudo A; Canonica GW; Nettis E; Asero R
J Eur Acad Dermatol Venereol; 2019 May; 33(5):918-924. PubMed ID: 30451325
[TBL] [Abstract][Full Text] [Related]
18. Most Patients With Autoimmune Chronic Spontaneous Urticaria Also Have Autoallergic Urticaria, but Not ViceVersa.
Xiang YK; Kolkhir P; Scheffel J; Sauer M; Vera C; Frischbutter S; Krause K; Siebenhaar F; Metz M; Maurer M; Altrichter S
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2417-2425.e1. PubMed ID: 36805105
[TBL] [Abstract][Full Text] [Related]
19. IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab.
Maronese CA; Ferrucci SM; Moltrasio C; Lorini M; Carbonelli V; Asero R; Marzano AV; Cugno M
J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615181
[No Abstract] [Full Text] [Related]
20. What Basophil Testing Tells Us About CSU Patients - Results of the CORSA Study.
Marcelino J; Baumann K; Skov PS; Pereira Santos MC; Wyroslak I; Scheffel J; Altrichter S; Woetmann A; Pereira-Barbosa M; Costa C; Maurer M
Front Immunol; 2021; 12():742470. PubMed ID: 34650565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
